Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Solzyme Drops
- Development stage
- Unknown
- Lead developer
- Boffin Biotech
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Solzyme Drops is a pediatric oral digestive enzyme formulation developed and marketed by Boffin Biotech. It is designed to support healthy digestion and alleviate symptoms of indigestion, flatulence, and dyspepsia in infants and young children. The formulation typically contains a combination of digestive enzymes, such as fungal diastase and pepsin, which assist in the breakdown of complex carbohydrates and proteins, thereby enhancing nutrient absorption and gastrointestinal comfort.
- Brand names
- Solzyme Drops
Beyond the preview
Go deeper on Solzyme Drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solzyme Drops.